[Federal Register Volume 84, Number 61 (Friday, March 29, 2019)]
[Notices]
[Page 11977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06088]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This meeting is open to the 
public, is limited only by room seating available, (120). The public is 
also welcome to listen to the meeting via teleconference at 888-455-
9748, passcode: 4373458; 100 teleconference lines are available. Time 
will be available for public comment. The public is welcome to submit 
written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt of written public comment is May 2, 2019. All 
requests must contain the name, address, and organizational affiliation 
of the speaker, as well as the topic being addressed. Written comments 
should not exceed one single-spaced typed page in length and delivered 
in 3 minutes or less. Members of the public who wish to provide public 
comments should plan to attend the public comment session at the start 
time listed. Please note that the public comment period may end before 
the time indicated, following the last call for comments. Written 
comments received in advance of the meeting will be included in the 
official record of the meeting. Registration is required to attend in 
person or on the phone. Interested parties must be processed in 
accordance with established federal policies and procedures and may 
register at https://www.cdc.gov/hicpac/.

DATES: The meeting will be held on May 16, 2019, 9:00 a.m. to 5:00 
p.m., EDT, and May 17, 2019, 9:00 a.m. to 12:00 p.m., EDT.

ADDRESSES: Centers for Disease Control and Prevention, Global 
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE, 
Atlanta, Georgia 30329-4027 and teleconference at 888-455-9748, 
passcode: 4373458.

FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton 
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027 Telephone (404) 
498-0730. Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, 
Health and Human Services, regarding (1) the practice of healthcare 
infection prevention and control; (2) strategies for surveillance, 
prevention, and control of infections, antimicrobial resistance, and 
related events in settings where healthcare is provided; and (3) 
periodic updating of CDC guidelines and other policy statements 
regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters To Be Considered: The agenda will include updates on CDC's 
activities for prevention of healthcare-associated infections. It will 
also include updates from the following HICPAC workgroups: The 
Healthcare Personnel Guideline Workgroup and the Neonatal Intensive 
Care Unit (NICU) Guideline Workgroup. The agenda also includes updates 
on CDC and DHQP activities. Agenda items are subject to change as 
priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06088 Filed 3-28-19; 8:45 am]
BILLING CODE 4163-19-P